Effects of vercirnon on the activity of CYP3A4, CYP2C19 and CYP2C8 enzymes and BCRP and OATP1B1 transporters using probe substrates

被引：0
|
作者：
Lynda J. Haberer
Iain McSherry
Anna Cargill
Linda McCarthy
机构：
[1] GlaxoSmithKline,Clinical Pharmacology Modelling & Simulation
[2] GlaxoSmithKline,Clinical Pharmacology Sciences and Study Operations
[3] PHASTAR,Statistics and Programming
[4] GlaxoSmithKline,Genetics
来源：
European Journal of Clinical Pharmacology | 2014年 / 70卷
关键词：
Drug interaction; Vercirnon; CYP3A4; CYP2C19; CYP2C8; BCRP; OATP1B1;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：37 / 45
页数：8
相关论文
共 50 条
  • [21] Characterization of CYP1A2, CYP2C19, CYP3A4 and CYP3A5 polymorphisms in South Brazilians
    Fabiana B. Kohlrausch
    Ángel Carracedo
    Mara H. Hutz
    Molecular Biology Reports, 2014, 41 : 1453 - 1460
  • [22] Characterization of CYP1A2, CYP2C19, CYP3A4 and CYP3A5 polymorphisms in South Brazilians
    Kohlrausch, Fabiana B.
    Carracedo, Angel
    Hutz, Mara H.
    MOLECULAR BIOLOGY REPORTS, 2014, 41 (03) : 1453 - 1460
  • [23] Effect of fifteen CYP3A4 in vitro inducers on the induction of CYP2B6, CYP2C8, CYP2C9, CYP2C19 and CYP3A5 in plated human hepatocytes: a trend analysis
    Zhang, J. George
    Patel, Reena
    Clark, Robert J.
    Ho, Thuy
    Trisdale, Sarah K.
    Stresser, David M.
    DRUG METABOLISM REVIEWS, 2016, 48 : 84 - 84
  • [24] REVERSIBLE AND TIME-DEPENDENT INHIBITION (TDI) OF CYP1A2, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6 AND CYP3A4 IN HUMAN HEPATOCYTE SUSPENSIONS BY MODEL INHIBITORS
    Zhang, J. George
    Thuy Ho
    Patel, Reena
    Trisdale, Sarah K.
    Creegan, Tim
    Stresser, David M.
    DRUG METABOLISM AND PHARMACOKINETICS, 2017, 32 (01) : S57 - S58
  • [25] Mechanism-based inactivation (MBI) of recombinant CYP2C19 and CYP3A4 but not human liver microsomal CYP2C19 and CYP3A4 by nortriptyline
    Polasek, Thomas M.
    Miners, John O.
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 234 - 234
  • [26] Characterisation of CYP2C8, CYP2C9 and CYP2C19 polymorphisms in a Ghanaian population
    Kudzi, William
    Dodoo, Alexander N. O.
    Mills, Jeremy J.
    BMC MEDICAL GENETICS, 2009, 10
  • [27] Quinidine as a probe for CYP3A4 activity: Intrasubject variability and lack of correlation with probe-based assays for CYP1A2, CYP2C9, CYP2C19, and CYP2D6
    Damkier, P
    Brosen, K
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 68 (02) : 199 - 209
  • [28] Factors regulating expression of CYP2C8, CYP2CC9 and CYP2C19
    Raucy, JL
    FASEB JOURNAL, 2000, 14 (08): : A1306 - A1306
  • [29] Relative roles of CYP2C19 and CYP3A4/5 in midazolam 1′-hydroxylation
    Emoto, C.
    Iwasaki, K.
    XENOBIOTICA, 2007, 37 (06) : 592 - 603
  • [30] Suppression of CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A4/5 activity by a cocktail of inflammatory cytokines
    Foster, John
    Webber, Guy
    Ormsby, Terry
    Cheung, Yen-Ling
    Paul, Danny S.
    Webber, Colin
    Waring, Adrian
    DRUG METABOLISM REVIEWS, 2016, 48 : 89 - 89
12345